Family Med Journals

Family Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kelly T et al. - A high percentage of bipolar II and bipolar NOS patients with treatment resistant depression improved on T3. Despite the use of higher than usual doses in many of the patients, the medication was well tolerated. Augmentation with supraphysiologic doses of T3 should be considered in cases of treatment resistant bipolar depression.

Methods

Results

Related Articles

Safety and Efficacy of Quetiapine in Bipolar Depression
Annals of Pharmacotherapy, 10/13/09    Relevance Score: 67%

Mecamylamine ? a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
Expert Opinion in Pharmacotherapy, 11/02/09    Relevance Score: 64%

Bipolar Disorder Patient Care Opportunities: Let's Answer the Call
Annals of Pharmacotherapy, 10/16/09    Relevance Score: 46%

Subgenual cingulate volumes in offspring of bipolar parents and in sporadic bipolar patients
European Archives of Psychiatry and Clinical Neuroscience, 10/13/09    Relevance Score: 46%

Sodium Load Combined with Low Doses of Exogenous Angiotensin II Upregulate Intrarenal Angiotensin II
Kidney and Blood Pressure Research, 10/08/09    Relevance Score: 46%

Today in Psychiatry...keeping you current

Treatment of Late-Life Depression Alleviates Caregiver Burden
Journal of the American Geriatrics Society, 11/30/09

Somatisation in primary care: experiences of primary care physicians involved in a training program and in a randomised controlled trial
BMC Family Practice, 11/30/09

Depression and Advanced Complications of Diabetes: a Prospective Cohort Study
Diabetes Care, 11/30/09